Katherine Yang, PharmD, MPH

Professor

Kathy Yang, Pharm.D., MPH is a Health Sciences Clinical Professor in the Department of Clinical Pharmacy at the University of California (UCSF) School of Pharmacy and an Infectious Diseases Clinical Pharmacist in the UCSF Medical Center. Dr. Yang specializes in the treatment of multi-drug resistant infections, particularly gram negative bacteria such as Pseudomonas aeruginosa. Her area of research focuses on the pharmacodynamic optimization of antibiotics for the treatment of biofilm-mediated infections such as cystic fibrosis.

Within the School of Pharmacy, Dr. Yang is involved in multiple aspects of the curriculum related to infectious diseases. Dr. Yang is also the co-director of Foundations, the first course of the Pharm.D. curriculum.
Education
MPH, 2001 - Public Health, University of California, Berkeley
Residency in Infectious Diseases, 2000 - Infectious diseases, University of California, San Francisco
Residency in Pharmacy Practice, 1999 - Pharmacy, University of California, San Francisco
Pharm.D., 1998 - Pharmacy, University of California, San Francisco
Honors and Awards
  • Fellow, California Society of Health-Systems Pharmacists, 2006
  • Long Prize for Excellence in Teaching, UCSF School of Pharmacy, 2005
Websites
Publications

  1. Highet A, Kendrick DE, Bandeh-Ahmadi H, Vitous A, Yang K, Ernst C, George BC. Pragmatic Mentoring Strategies for the Busy Surgeon Scientist. 2022. PMID: 35144902


  2. Trinh TD, Strnad L, Damon L, Dzundza JH, Graff LR, Griffith LM, Hilts-Horeczko A, Olin R, Shenoy S, DeVoe C, Wang L, Rodriguez-Monguio R, Gu TM, Hampton SR, Macapinlac BAC, Yang K, Doernberg SB. Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis. 2021. PMID: 33487182


  4. Huang L, Haagensen JAJ, Verotta D, Cheah V, Spormann AM, Aweeka F, Yang K. Determination of Tobramycin in M9 Medium by LC-MS/MS: Signal Enhancement by Trichloroacetic Acid. 2018. PMID: 29854560


  5. Verotta D, Haagensen J, Spormann AM, Yang K. Mathematical Modeling of Biofilm Structures Using COMSTAT Data. 2017. PMID: 29422943


  6. Haagensen J, Verotta D, Huang L, Engel J, Spormann AM, Yang K. Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms. 2017. PMID: 28961810


  7. Trang TP, Hanretty AM, Langelier C, Yang K. Use of isavuconazole in a patient with voriconazole-induced QTc prolongation. 2017. PMID: 28434195


  8. Haagensen JA, Verotta D, Huang L, Spormann A, Yang K. New in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilms. 2015. PMID: 25918138


  9. Huang L, Haagensen J, Verotta D, Lizak P, Aweeka F, Yang K. Determination of meropenem in bacterial media by LC-MS/MS. 2014. PMID: 24861874


  11. Sohn AH, Schwartz JM, Yang KY, Jarvis WR, Guglielmo BJ, Weintrub PS. Risk factors and risk adjustment for surgical site infections in pediatric cardiothoracic surgery patients. 2010. PMID: 20605267


  12. Yang, K
    MacDougall C
    Wiener-Kronish J. An Evidenced-based Practice in Critical Care 2010. PMID:


  13. Steinman MA, Yang KY, Byron SC, Maselli JH, Gonzales R. Variation in outpatient antibiotic prescribing in the United States. 2009. PMID: 20001167


  15. Zhuo H, Yang K, Lynch SV, Dotson RH, Glidden DV, Singh G, Webb WR, Elicker BM, Garcia O, Brown R, Sawa Y, Misset B, Wiener-Kronish JP. Increased mortality of ventilated patients with endotracheal Pseudomonas aeruginosa without clinical signs of infection. 2008. PMID: 18679122


  16. Lynch SV
    Yang K
    Brodie EL
    MacDougall C
    Andersen G
    Wiener-Kronish JP. Culture-Independent Bacterial Population Analysis - Clinical Implications for Respiratory and Other Infections 2008. PMID:


  20. Yang K
    Graff L
    Caughey A. Blueprints Notes and Cases 2003. PMID:


  21. Yang K, Guglielmo BJ. Patient education for H pylori: who benefits? 2002. PMID: 11897729